About us Contacts Drug interactions: 390 212
Drug search by name

Disopyramide Capsules and Kaletra Oral Solution

Determining the interaction of Disopyramide Capsules and Kaletra Oral Solution and the possibility of their joint administration.

Check result:
Disopyramide Capsules <> Kaletra Oral Solution
Relevance: 11.04.2023 Reviewer: Shkutko P.M., M.D., in

In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.

Consumer:

Ritonavir may significantly increase the blood levels of disopyramide. This can increase side effects such as dry mouth, abdominal pain, constipation, blurred vision, difficulty urinating, low blood sugar, low blood pressure, and potentially life-threatening irregular heart rhythm and conduction abnormalities. Talk to your doctor if you have any questions or concerns. Your doctor may be able to prescribe alternatives that do not interact, or you may need a dose adjustment or special monitoring by your doctor to safely use both medications. You should seek immediate medical attention if you develop sudden dizziness, lightheadedness, fainting, shortness of breath, or heart palpitations during treatment with disopyramide. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.

Professional:

MONITOR CLOSELY: Coadministration with potent inhibitors of CYP450 3A4 may significantly increase the plasma concentrations of disopyramide, which is primarily metabolized by the isoenzyme. High plasma levels of disopyramide may increase the risk of QT interval prolongation, which has been associated with ventricular arrhythmias including torsade de pointes and sudden death. Other adverse effects such as hypoglycemic coma and ventricular fibrillation have also been reported.

MANAGEMENT: Caution is advised when disopyramide must be used concomitantly with potent CYP450 3A4 inhibitors. Pharmacologic response and disopyramide levels should be monitored more closely whenever a potent CYP450 3A4 inhibitor is added to or withdrawn from therapy, and the disopyramide dosage adjusted as necessary.

References
  • "Product Information. Norpace (disopyramide)." Searle, Skokie, IL.
Disopyramide Capsules

Generic Name: disopyramide

Brand name: Norpace, Norpace CR

Synonyms: Disopyramide

Kaletra Oral Solution

Generic Name: lopinavir / ritonavir

Brand name: Kaletra

Synonyms: Kaletra

In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.

Interaction with food and lifestyle